Delayed administration of a single dose of lithium promotes recovery from AKI.
about
Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular diseaseActivation of glycogen synthase kinase 3β ameliorates diabetes-induced kidney injury.Fine-tuning of NFκB by glycogen synthase kinase 3β directs the fate of glomerular podocytes upon injury.Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.Dual effect of lithium on NFAT5 activity in kidney cells.Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action.The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.Rescue therapy with Tanshinone IIA hinders transition of acute kidney injury to chronic kidney disease via targeting GSK3β.Designing drugs that combat kidney damage.Necroinflammation in Kidney Disease.Lithium in the Kidney: Friend and Foe?What we need to know about the effect of lithium on the kidney.Molecular mechanisms in lithium-associated renal disease: a systematic review.Competing Actions of Type 1 Angiotensin II Receptors Expressed on T Lymphocytes and Kidney Epithelium during Cisplatin-Induced AKI.Lithium in kidney diseases: big roles for the smallest metalEpoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling.Lithium reduces blood glucose levels, but aggravates albuminuria in BTBR-ob/ob mice.Renal Tubule Repair: Is Wnt/β-Catenin a Friend or Foe?
P2860
Q26996385-A1422239-F7C0-4E0A-A8FE-DA3C17A67E32Q34737936-AB137BE4-B14D-4BD8-AE7D-E97903781E4FQ35667727-276519EF-B8BE-4B11-A46E-E2F3DEA20905Q35923493-5F483CEE-B7E0-49EF-998B-F2916741743CQ36098316-4FB27E27-CF4E-4B05-88EE-90DD73CF73CDQ36217903-225BD7FF-CF76-4A20-9404-157DA9E3CF1EQ36803722-419D415F-875F-4BE9-81FB-EFBEA68DD199Q37421807-37B64EEF-3F5D-4452-A01B-F78F4BF4ED2AQ38404587-38BAEC22-BC75-4B45-A169-FB99633F2E91Q38579499-CDB20B00-06E4-4002-96E9-313C9D790314Q38636263-9017BBCE-A2F6-4DAF-8A01-DCA934258272Q38819531-735DF32A-AA37-492E-A83F-8688734D19D1Q38847068-C93144E6-B5CD-4C1B-B664-B8DAC42D3226Q41885649-A27ADF6E-F36F-443A-9FAD-5DFDC286EFCCQ42429839-B1C0B2D3-4465-44EE-ACE7-2E0A96A099FBQ46028902-1A0BD9FE-2F80-470E-8F8D-BA0E399C16CCQ47105160-C732CAA0-E0E6-4D3E-A3A6-D156A0CC2030Q49827937-10A08B05-2E24-4364-BA0D-7DA46DC8971B
P2860
Delayed administration of a single dose of lithium promotes recovery from AKI.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Delayed administration of a single dose of lithium promotes recovery from AKI.
@en
Delayed administration of a single dose of lithium promotes recovery from AKI.
@nl
type
label
Delayed administration of a single dose of lithium promotes recovery from AKI.
@en
Delayed administration of a single dose of lithium promotes recovery from AKI.
@nl
prefLabel
Delayed administration of a single dose of lithium promotes recovery from AKI.
@en
Delayed administration of a single dose of lithium promotes recovery from AKI.
@nl
P2093
P2860
P356
P1476
Delayed administration of a single dose of lithium promotes recovery from AKI.
@en
P2093
P2860
P304
P356
10.1681/ASN.2013040350
P50
P577
2014-01-09T00:00:00Z